AstraZeneca PLC (ADR)
General ticker "AZN" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $514.7B (TTM average)
AstraZeneca PLC (ADR) follows the US Stock Market performance with the rate: 42.7%.
Estimated limits based on current volatility of 1.3%: low 176.27$, high 180.82$
Factors to consider:
- Company included in NASDAQ-100 index
- Company pays dividends (semi-annually): last record date 2026-02-20, amount 2.17$ (Y2.46%)
- Total employees count: 6000 as of 2010
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [137.49$, 194.74$]
- 2026-12-31 to 2027-12-31 estimated range: [144.40$, 203.50$]
Short-term AZN quotes
Long-term AZN plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $58,739.00MM |
| Operating Expenses | $44,996.00MM |
| Operating Income | $13,743.00MM |
| Non-Operating Income | $-1,341.00MM |
| Interest Expense | $1,694.00MM |
| R&D Expense | $14,232.00MM |
| Income(Loss) | $12,402.00MM |
| Taxes | $2,169.00MM |
| Net Income(Loss)* | $10,255.00MM |
| Stockholders Equity | $48,667.00MM |
| Inventory | $6,557.00MM |
| Assets | $114,074.00MM |
| Operating Cash Flow | $14,575.00MM |
| Capital expenditure | $2,810.00MM |
| Investing Cash Flow | $-6,808.00MM |
| Financing Cash Flow | $-7,544.00MM |
| Earnings Per Share** | $6.62 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.